Connect with us

Health

Cognito Therapeutics Initiates Studies in Down Syndrome Associated Alzheimer’s Disease – Business Wire

Cognito Therapeutics Initiates Studies in Down Syndrome Associated Alzheimer’s Disease

Published

on

Article feature image

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cognito Therapeutics, a clinical-stage company leading the development of a new class of disease-modifying digital therapeutics to treat neurodegenerative disorders including Alzheimers disease, announced today its plans…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Daily coronavirus infections are suddenly dropping in the UK, but not all is as it seems – ABC News
Article feature image
Should face masks be made mandatory for children in schools? – ABC News